Evolution Health Group
Independent
Address
One Blue Hill Plaza, 8th Floor
Pearl River, New York 10965
Web Address
Year Founded
2005
Full-time Employees
131
Number of Clients
40
North American Revenue 2021
Full-time Employees 2021
Number of clients 2021
Offices
North America
3
Locations
Pearl River, NY
Philadelphia, PA
Montreal, Quebec, Canada
Executives & Senior Management
Mark Edfort
Managing Partner
Carolyn Vogelesang Harts
Managing Partner
Andrea Lanzetta
Managing Partner
Senior Management
Mark Edfort
Managing Partner
Carolyn Vogelesang Harts
Managing Partner
Andrea Andrea
Managing Partner
Leo Francis
Chief Operating Officer
Maureen Drexler
SVP, Operational Excellence
Angela Searles
SVP, Maestro360
Jeffrey Freedman
EVP, blulava
Jon Mufson
Director, Talent Acquisition
Scott Reese
Senior Director, Digital Strategy and Customer Engagement, blulava
Jon Alfisi
VP, Technology Solutions, blulava
Lynn Alter
SVP, Speakers Bureau Strategy, Maestro360
Kathleen Oakley
Director, Human Resources, Evolution Health Group
Agency 100 Book Cover
Capabilities/Services Offered
Professional
Consumer
Direct Marketing
Med-ed
Payer
Med-Tech
Data/Analytics
Digital
New Services
Yes, we expanded our trademarked offerings around our 360Connex platform to include even greater insight generation capabilities and in the area of innovative offerings around understanding customer behavior
Client Roster
Lundbeck, Northera
Apellis, Pegcetacoplan
CSL Behring, Hizentra
Sanofi-Genzyme, Amcenestrant
Janssen Biotech, Imbruvica
Janssen Biotech, Erleada
Jannsen Biotech, Tar200
Janssen Biotech, Rybrevant
Jannsen Biotech, Darzalex
Akebia, Auryxia
Akebia, vadadustat
Aimmune, Palforzia
Averitas, Qutenza
Sun, Odomzo
Sun, Yonsa
Sun, LTC
Biogen, Vumerity
Biogen, Tecfidera
Biogen, Tysabri
Biogen, aducanumab
Biogen, Fumerates
Corium, Azstarys
Alnylam, Onpattro
Alnylam, Lumasiran
Ferring, Nocdurna
Ferring, Euflexxa
Ferring, Menopur
Ferring, Endometrin
Ferring, Clenpiq
Ferring, Milprosa
Ferring, Cimzia
Ferring, Microbiome
Ferring, Invocell
AstraZeneca, BRILINTA
AstraZeneca, FARXIGA
AstraZeneca, LOKELMA
Takeda, Natpara
Takeda, VPRIV
Takeda, Takhzyro
Takeda, Elaprase
Takeda, Cuvitru
Takeda, HyQvia
Takeda, Gattex
Takeda, Glassia
Takeda, Advate
Takeda, Adynovate
Takeda, Feiba
Takeda, Vonvendi
Takeda, Obizur
Takeda, GammagardTakeda, Entyvio
Takeda, Motegrity
Takeda, Vyvanse
Takeda, Trintellix
Takeda, Mydayis
Incyte, Jakafi
Incyte, Pemazyre
Incyte, Monjuvi
Rhythm, Imcivree
BioMarin, Valrox
Growth
2021 Growth from Existing Clients
73%
2021 Growth from New Clients
27%
Trends and Challenges
Talent acquisition/retention
Managing growth
Procurement-related issues
Shrinking pharma budgets
Pandemic-related disruptions
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Industry consolidation
Scrutiny around social media
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Decreased impact of sales forces
Regulatory changes
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Seizing opportunities around cannabis
Working from home
Ongoing fallout from pandemic
Creative Samples
